(Q37765245)

22 August 2017

Marginal zone lymphomas: factors that affect the final outcome (English)

1 reference

22 August 2017

7

Barbara Pro

0 references

Luis E. Fayad

6

object named as

Luis E Fayad

0 references

Bouthaina S Dabaja

11

object named as

Bouthaina S Dabaja

1 reference

22 August 2017

Ali Mazloom

1

1 reference

22 August 2017

L Jeffrey Medeiros

2

1 reference

22 August 2017

Peter W McLaughlin

3

1 reference

22 August 2017

Valerie Reed

4

1 reference

22 August 2017

Fernando F Cabanillas

5

1 reference

22 August 2017

Graciela Gonzalez

8

1 reference

22 August 2017

Puneeth Iyengar

9

1 reference

22 August 2017

Diana L Urbauer

10

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

22 August 2017

1 reference

22 August 2017

116

1 reference

22 August 2017

4291-4298

1 reference

22 August 2017

18

1 reference

MALT lymphoma: from morphology to molecules

22 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

The pathogenesis of MALT lymphomas: where do we stand?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Splenic marginal zone lymphoma: a prognostic model for clinical use.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Dissemination patterns in non-gastric MALT lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Nongastric marginal zone B-cell lymphoma: analysis of 247 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25325

7 January 2021

Identifiers

DOI

10.1002/CNCR.25325

1 reference

22 August 2017

1 reference